Bionova Scientific to expand its biologics manufacturing operations at its Fremont, California

Last edition

Bionova Scientific to expand its biologics manufacturing operations at its Fremont, California

California-based Bionova Scientific is gearing up to expand its biologics manufacturing operations at its Fremont, California, facility. The project will kick off an initiative to broaden its services portfolio to include more technical capabilities and therapies.

The new facility will replace the headquarters and development centre, allowing for increased manufacturing operations. The completion of the project is slated for later this year.

Read more on:
Bionova Scientific Pharma Facility Pharma Manufacturing

More news about: manufacturing | Published by Sudeep Soparkar | February - 04 - 2023 | 570

Last news about this category

TESTA Analytical Launches Audit Ready Tool for HPLC Pump Validation

Chiesi Acquires New Manufacturing Site in Milan with EUR 430 Million Investment

CARBOGEN AMCIS Receives GMP Certification for Aseptic Drug Product Manufacturing Site

Cytiva Announces Expansion of Xcellerex X-Platform with Addition of 500L and 2000L Bioreactors

Gattefosse Secures Certifications for its New Manufacturing Plant in Texas

Syngene Acquires its First Manufacturing Facility in US

Limula Rolls Out LimONE for Seamless Workflow in Cell Therapy Manufacturing

CordenPharma Expands Peptide Platform with Greenfield Facility Construction in Switzerland

Axplora Expands Commercial ADC Manufacturing with New Workshop Launch in France

Hanmi Pharmaceutical Rolls Out New Automated Vial Dispensing Solution in Canada and US

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy